{
}
Merck's cardiovascular drug Winrevair has shown promising results in the ZENITH trial, significantly improving survival and reducing the need for invasive care in patients with severe lung hypertension compared to those on standard therapy. The trial was halted early due to its clear efficacy, potentially expanding the drug's use and driving sales, which are projected to reach $5 billion annually. Winrevair, approved earlier this year, treats pulmonary arterial hypertension and has already generated $219 million in sales through September 30.
Musk's rivalry with Bezos intensifies as Trump’s victory boosts Musk's influence in the space industry. While Bezos attempts to mend ties with Trump, Musk enjoys a favorable relationship, raising concerns among competitors about potential favoritism in government contracts and NASA leadership. Blue Origin fears Musk's ambitions could undermine competition and national security in the space sector.
The healthcare nanotechnology market is projected to grow from $308.03 billion in 2023 to $351.82 billion in 2024, with a CAGR of 14.2%, driven by rising cancer cases and advancements in nanomedicine. By 2028, the market is expected to reach $613.9 billion, fueled by innovations in theranostics and personalized medicine. North America led the market in 2023, highlighting the region's significant role in this expanding field.
The farm animal healthcare market is projected to grow from $19.77 billion in 2023 to $28.07 billion by 2028, driven by increasing livestock populations and rising global food demand. Key trends include advancements in biotechnology, digital health solutions, and eco-friendly practices. Major players in the market include Bayer AG, Merck & Co. Inc., and Zoetis Inc.
The North America oncology drugs market, valued at USD 10.13 billion in 2023, is projected to grow at a CAGR of 10.38%, reaching USD 27.20 billion by 2033. Key drivers include advances in cancer research, rising cancer prevalence, and increasing demand for personalized medicine, while challenges include high drug costs and stringent regulations. The market is segmented into cytotoxic, targeted, and hormonal drugs, with targeted therapies expected to dominate due to their effectiveness and reduced toxicity.
The Global Pediatric Healthcare market is projected to grow from $175.6 billion in 2024 to $290 billion by 2032, with a CAGR of 6.5%. Key players include Abbott, Pfizer, and Merck, focusing on pharmaceuticals, nutrition, medical devices, and vaccines across various applications like hospitals and homecare. The market is expanding rapidly in the Asia-Pacific region, while North America remains the dominant market.
The equine healthcare market is projected to grow from $1.34 billion in 2023 to $1.81 billion by 2028, driven by factors such as an aging equine population, increased awareness of animal health, and advancements in healthcare solutions. Key players include Merck, Bayer, and Zoetis, focusing on innovative products like protein-based vaccines. North America remains the largest market, with significant investments in animal healthcare infrastructure supporting this expansion.
Merck announced that its injectable version of Keytruda is not inferior to the approved intravenous formulation in a late-stage trial for lung cancer patients. The injectable method, which takes about 2-3 minutes to administer, could enhance accessibility and protect the drug from future competition as the IV version nears patent expiration. Merck plans to engage with global regulators regarding these promising results.
The Equine Healthcare Market is projected to grow at a CAGR of 4.2% from 2024 to 2031, driven by rising demand for veterinary care, advanced treatments, and preventive measures for horses. Key players include Purina Animal Nutrition, Elanco Animal Health, and Boehringer Ingelheim, focusing on products like vaccines, pharmaceuticals, and diagnostics. The market"s expansion is fueled by increased awareness of equine health, growth in the equestrian sports industry, and advancements in veterinary technologies.
The global Hashimoto"s thyroiditis market is projected to grow from $8.3 billion in 2023 to $12.6 billion by 2033, with a CAGR of 4.26%. North America is expected to dominate the market, while Asia-Pacific will experience the fastest growth due to rising healthcare awareness and improved infrastructure. The tablet segment will hold the largest market share, driven by convenience and patient compliance.
Merck & Co., Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Merck's Winrevair shows promise in severe lung hypertension treatment trial
01:00 25.11.2024
Musk and Bezos vie for dominance in space amid political favoritism
Microsoft Corporation
Amazon.com, Inc.
Tesla, Inc.
General Motors Company
Merck & Co., Inc.
SpaceX
Harley-Davidson, Inc.
Blue Origin
USA
Kathy Lueders
Charles A. Miller
Kamala Harris
Donald Trump
Elon Musk
Jeff Bezos
David Limpacher
Show more
13:45 24.11.2024
healthcare nanotechnology market poised for rapid growth driven by cancer cases
United States Dollar
Luminex Corporation
Sanofi
Mallinckrodt plc
Abbott Laboratories
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company
Pfizer Inc.
Merck & Co., Inc.
Johnson & Johnson Inc.
Celgene Corporation
GE HealthCare Technologies Inc.
Show more
15:59 22.11.2024
farm animal healthcare market projected to reach 28 billion by 2028
14:32 22.11.2024
rth america oncology drugs market projected to reach 27.20 billion by 2033
United States Dollar
Novartis AG
Gilead Sciences, Inc.
Sanofi
Takeda Pharmaceutical Company Limited
Johnson & Johnson
Amgen Inc.
Bristol-Myers Squibb Company
Biogen Inc.
AstraZeneca PLC
Roche Holding AG
Pfizer Inc.
Merck & Co., Inc.
Celgene Corporation
AbbVie Inc.
Eli Lilly and Company
USA
Show more
14:29 22.11.2024
global pediatric healthcare market poised for significant growth through 2032
Siemens Healthineers AG
Pfizer Inc.
Medtronic
Johnson & Johnson
Danone S.A.
Philips
Merck & Co., Inc.
GlaxoSmithKline
Nestlé S.A.
The Procter & Gamble Company
GE HealthCare Technologies Inc.
Reckitt Benckiser Group plc
Bristol-Myers Squibb Company
Sanofi
Boston Scientific Corporation
Hoffmann-La Roche AG
Abbott
Novartis AG
Bayer
USA
IND
VNM
THA
IDN
SGP
MYS
JPN
KOR
HKG
AUS
PHL
TWN
CHN
Nidhi Bhawsar
Show more
17:31 20.11.2024
global equine healthcare market projected to reach 1.81 billion by 2028
Merck & Co., Inc.
Boehringer Ingelheim KG
Zoetis Inc.
Bayer AG
Sanofi
USA
Zoetis Inc.
Boehringer Ingelheim
Bayer AG
Sanofi S.A.
Merck & Co. Inc.
Show more
00:30 20.11.2024
merck"s injectable keytruda shows comparable efficacy to intravenous formulation in trial
13:22 19.11.2024
equine healthcare market projected to grow at 4.2 percent through 2031
Zoetis Inc.
Merck & Co., Inc.
Vetoquinol SA
Boehringer Ingelheim KG
Elanco Animal Health Incorporated
Ceva Sante Animale SA
Purina Animal Nutrition LLC
Elanco Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Equine products UK LTD
Purina Animal Nutrition LLC
Show more
08:07 19.11.2024
global hashimoto thyroiditis market projected to reach 12.6 billion by 2033
United States Dollar
Amgen Inc.
Merck & Co., Inc.
Novartis AG
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company
Takeda Pharmaceuticals Limited Company
Bayer AG
Pfizer Inc.
Roche Holding AG
AbbVie Inc.
AstraZeneca PLC
Eli Lilly and Company
Glaxosmithkline plc
ARG
GBR
FRA
ITA
KOR
ZAF
MEX
USA
BRA
ESP
SAU
CAN
QAT
ARE
JPN
AUS
DEU
CHN
RUS
IND
Pfizer Inc.
AbbVie Inc.
Mylan N.V.
Inc.
Merck & Co
GlaxoSmithKline plc
Show more
04:38 19.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Private Equity Deals
Supply Chain Management
Government Economic Policies
Cryptocurrency Trends
Retail and Consumer Goods
Fintech Startups
Workplace Trends
Central Bank Actions
Central Banks and Digital Currencies
Venture Capital Investments
CEO Changes
Finance Mergers & Acquisitions
Energy Sector Developments
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Tencent Holdings Ltd
Google Inc.
NIO Inc.
Nikkei 225
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
People: